Unknown

Dataset Information

0

Extramedullary acute myeloid leukemia presenting in young adults demonstrates sensitivity to high-dose anthracycline: a subset analysis from ECOG-ACRIN 1900.

ABSTRACT:

SUBMITTER: Fernandez HF 

PROVIDER: S-EPMC6442974 | biostudies-literature | 2019 Apr

REPOSITORIES: biostudies-literature

Json Xml
altmetric image

Publications

Extramedullary acute myeloid leukemia presenting in young adults demonstrates sensitivity to high-dose anthracycline: a subset analysis from ECOG-ACRIN 1900.

Fernandez Hugo F HF   Sun Zhuoxin Z   Litzow Mark R MR   Luger Selina M SM   Paietta Elisabeth E   Racevskis Janis J   Levine Ross L RL   Patel Jay P JP   Abdel-Wahab Omar O   Ketterling Rhett P RP   Dewald Gordon W GW   Bennett John M JM   Rowe Jacob M JM   Lazarus Hillard M HM   Tallman Martin S MS  

Haematologica 20181122 4

Similar Datasets

Unknown The relationship between clinical trial accrual volume and outcomes in acute myeloid leukemia: A SWOG/ECOG-ACRIN study (S0106 and E1900).
| S-EPMC6615032 | biostudies-literature
Unknown Quality control for digital tomosynthesis in the ECOG-ACRIN EA1151 TMIST trial.
| S-EPMC11332660 | biostudies-literature
Unknown Obesity in adult acute myeloid leukemia is not associated with inferior response or survival even when dose capping anthracyclines: An ECOG-ACRIN analysis.
| S-EPMC10932613 | biostudies-literature
Unknown Germline predictors for bevacizumab induced hypertensive crisis in ECOG-ACRIN 5103 and BEATRICE.
| S-EPMC11014938 | biostudies-literature
Unknown Academic Community Partnership in Acute Promyelocytic Leukemia and Early Mortality: The ECOG-ACRIN EA9131 Trial.
| S-EPMC11869096 | biostudies-literature
Unknown Smoking Behavior in Patients With Early-Stage NSCLC: A Report From ECOG-ACRIN 1505 Trial.
| S-EPMC8383783 | biostudies-literature
Unknown Independent Prognostic Significance of Monosomy 17 and Impact of Karyotype Complexity in Monosomal Karyotype/Complex Karyotype Acute Myeloid Leukemia: Results from Four ECOG-ACRIN Prospective Therapeutic Trials.
| S-EPMC5573653 | biostudies-literature
Unknown Cardiovascular Implications of Vascular Endothelial Growth Factor Inhibition Among Adolescents/Young Adults in ECOG-ACRIN E2805.
| S-EPMC10494962 | biostudies-literature
Unknown Preradiation Chemotherapy for Adult High-risk Medulloblastoma: A Trial of the ECOG-ACRIN Cancer Research Group (E4397).
| S-EPMC5352534 | biostudies-literature
Unknown A Cohort Study to Evaluate Genetic Predictors of Aromatase Inhibitor Musculoskeletal Symptoms: Results from ECOG-ACRIN E1Z11.
| S-EPMC11287923 | biostudies-literature